Francois MarteletChief Executive Officer
Share holdings: 896,739 stock options
Francois Martelet is an experienced Pharma executive with a proven track record of shaping companies and turning around underperforming units. He has held three CEO positions in the last 12 years. He has spent most of his career in the oncology field, as CEO of Avax and Topotarget, as well as in executive roles at senior level at Roche, Eli Lilly, Novartis and MSD. He has been based in six countries in Europe (including Sweden) and in the US. Francois Martelet is a French Medical Doctor, with a Masters Degree in Business. He speaks four languages, among them Swedish.
Elin TrampeChief Technical Officer
Share holdings: –
Elin Trampe has a Master of Science in Industrial Engineering and Management and has many years of experience from various leading positions within Supply Chain, Project Management and Category Development in large international companies. Most recently she was at General Electric Global Operations, working towards the Healthcare business.
Reinhard KoenigActing Chief Medical Officer
Share holdings: –
Reinhard Koenig has more than 30 years of pharma and biotechnology experience. He has extensive experience of leading positions within global pharmaceutical companies. Previous companies include Genentech, Boehringer Mannheim and Piramal Critical Care.
Michael af WinklerfeltChief Financial Officer
Share holdings: 84,960 shares.
Michael af Winklerfelt has more than 15 years of experience from senior finance roles in leading international companies. He worked for ten years in China for the Atlas Copco Group and most recently spent three years in the United States in the medical device field. He has an MBA, an M.Sc. in Economics and Business and an unfinished B.A. in Chinese.